HOME >> BIOLOGY >> NEWS
Other highlights in the July 24 JNCI

Hormone Therapy and Mammography Use Influence Breast Cancer Rates

A rise in breast cancer incidence from the 1980s through 2001 paralleled trends in mammography screening and hormone therapy use, while a recent decline in incidence was consistent with a drop in hormone therapy use, according to a study of a large group of women enrolled in a single health plan,.

Breast cancer incidence has been on the rise since the late 1930s, but a recent report showed the first statistically significant decline in breast cancer incidence in 2003. Over this period, rates of hormone therapy use and mammography screening have changed too, but their individual influence on breast cancer rates was unclear.

Andrew Glass, M.D., of Kaiser Permanentes Center for Health Research in Portland, Ore., and colleagues compared breast cancer incidence rates with mammography use and menopausal hormone therapy prescriptions among patients in the health plan between 1980 and 2006.

Among women 45 years and older, breast cancer incidence rose 25% from the early 1980s to the early 1990s and continued to rise but at a lower rate15%through 2001. The rates dropped by 18% from 2003 to 2004, and then edged up slightly in 2005 and 2006. This pattern was seen predominantly in estrogen receptor-positive breast cancers. Meanwhile, mammography screening rose from 1980 until 1993, then remained stable through 2006. Hormone therapy use increased from 1988 to 2002, when it dropped by 75%.

This rise [from the early 1980s to 2001] seemed to occur in two phases, the first during the 1980s, coinciding with the progressive adoption of screening mammography by 75%-79% of eligible women in the plan, and the second corresponding to increases in menopausal hormone use, particularly combined therapy, throughout the 1990s, the authors write.

In an accompanying editorial, Donald Berry, Ph.D., and Peter Ravdin, M.D., of the University of Texas M. D. Ander
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
24-Jul-2007


Page: 1 2 3 4

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights from the July 10 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... building awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced ... Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the ... of Care Testing solutions (POCT). Check local listings for more info. , Today, the ... and are shipped to labs throughout the country. Results are then available several days ...
(Date:6/23/2020)... , ... June 23, 2020 ... ... of gene-to-protein and monoclonal antibody development services, today announced that the company ... and services to the pharmaceutical, diagnostics, and research industries. The decision to ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter ... great surgery is only the beginning of a successful study, while protecting and accessing ... Brad Gien, Global Head of Surgery from Envigo in a live ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 08, 2020 , ... ... products, announces a significant expansion of laboratory operations through its COVID-19 testing ... implementing testing programs. , Bode-CARES provides a turnkey solution that ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using the ... pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over ... been using the zebrafish model to investigate the causes of leukaemia and its ...
Breaking Biology Technology:
Cached News: